48.11 0.00 (0.00%)
After hours: 4:17PM EDT
|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||47.19 - 48.57|
|52 Week Range||44.36 - 88.68|
|Beta (3Y Monthly)||0.98|
|PE Ratio (TTM)||22.27|
|Earnings Date||Apr 24, 2019 - Apr 29, 2019|
|Forward Dividend & Yield||1.48 (3.12%)|
|1y Target Est||77.88|
NU Skin Enterprises Inc NYSE:NUSView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is extremely low for NUS with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting NUS. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $2.78 billion over the last one-month into ETFs that hold NUS are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Stocks that moved substantially or traded heavily on Monday: Winnebago Industries Inc., down 10 cents to $29.01 The recreational vehicle company reported better-than-expected fiscal second-quarter profit. ...
The bearish sentiment toward Nu Skin reflected the uncertainty surrounding direct selling companies in China against the backdrop of an investigation announced early January into the unlawful promotion and sale of health products, leading up to a 100-day ban on business meetings, Astrachan said in a note. This, along with the recent death of the company's registered customer in China, has elicited strong reactions from two communist party publications, one of which called for an investigation into the death and the company's misleading advertising.
Nu Skin's stock price dropped 7.31% to $45.68 after the downgrade by Stifel Nicolaus analyst Mark Astrachan, who pointed to the potential of increased regulatory scrutiny in China into direct sales companies like Nu Skin, which focuses on wellness and beauty. The Chinese government launched a 100-day investigation on Jan. 8 into direct sales companies following the death of a 7-year-old cancer patient who was given an herb product touted as having anti-cancer powers instead of traditional medicine. Licenses required for direct sales companies like Nu Skin to do business have been suspended by the Chinese government during the investigation, as well a business meetings.
Shares of Nu Skin Enterprises Inc. sank 2.6% toward a fresh 2-year low in premarket trade Monday, adding to the 17% plunge over the previous five sessions, after Stifel Nicolaus analyst Mark Astrachan turned bearish on the direct seller of beauty and wellness products, citing increasing China uncertainty. Astrachan cut his rating back to sell, after upgrading it to hold in August, and slashed his price target to $43 from $63. The downgrade comes after China announced an investigation into direct selling companies and the unlawful promotion and sale of health products, which resulted in a 100-day ban on business meetings. Astrachan noted that recently a Nu Skin customer had died, after refusing medical treatment because they believed the company's products would treat their illness. "While the investigation does not yet specifically pertain to Nu Skin, we view increased scrutiny of the direct selling industry broadly and Nu Skin specifically as likely to impact category and company recruitment, negatively impacting sales and profit in a key market," Astrachan wrote in a note to clients. The stock has tumbled 19.7% year to date through Friday, while the S&P 500 has gained 11.7%.
When it comes to beauty products, worldwide consumption has a virtually bottomless appetite. Almost any female social media "influencer" pushes some version of health or beauty product, either their own (e.g., Kylie Jenner) or any one of the plethora of new and old brands on the market. Nu Skin Enterprises Inc. (NUS) has a hybrid model, somewhere between direct-selling and online retail, offering a broad array of branded health and beauty products in more than 50 countries across Europe, the Asia-Pacific and the Americas.
If you are currently a shareholder in Nu Skin Enterprises, Inc. (NYSE:NUS), or considering investing in the stock, you need to examine how the business generates cash, and how itRead More...
Zacks.com featured highlights include: Materion, Boston Beer , Nu Skin, Darden and Comfort Systems
Coty's (COTY) Luxury unit continues to deliver a strong show. Also, acquisitions and e-commerce efforts bode well amid hurdles like soft Consumer Beauty segment.
United Natural's (UNFI) Q2 results to gain from robust demand conditions and buyouts. However, rising fright costs and unfavorable consumer mix are concerns.
NEW YORK, March 01, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.
PROVO, Utah, Feb. 28, 2019 /PRNewswire/ -- As part of its annual investor day, Nu Skin Enterprises, Inc. today shared its long-term strategy for consistently sourcing pure, safe and effective ingredients for use in its products. To accomplish this, Nu Skin plans to build on its investment in Controlled Environment Agriculture (CEA) technologies to develop sustainable ingredients that are traceable from seed to solution. Nu Skin's CEA strategy grows out of a desire to provide consumers safe, effective and traceable product ingredients while drastically reducing the land and water resources required.
British American's (BTI) preliminary 2018 results to gain from robust pricing as well as growth in low-risk tobacco products.
Peru will begin operations on March 7, 2019, with a grand opening event in Lima, Peru. "Nu Skin's business in Latin America has seen incredible growth over the past year as our products and business opportunity continue to improve lives throughout the region," said Tyler Whitehead, West Region president. "Peru is a well-established market for direct selling, and we have seen great anticipation from potential customers and sales leaders there.
FEMSA's (FMX) fourth-quarter 2018 results might be hurt by higher operating expenses. However, its strategic actions to boost growth remain encouraging.
Herbalife Nutrition (NYSE:HLF) has won its long-running battle with the shorts. Herbalife stock is up 60% since the beginning of 2018, touching an all-time high earlier this month. And most shorts have moved on in the process: less than 10% of HLF stock is sold short at the moment, down from levels that were consistently above 25% as recently as 2017.Source: Shutterstock But Herbalife stock is pulling back slightly in trading on Wednesday. HLF is down 2.6% as of this writing after its fourth-quarter earnings report on Tuesday afternoon. The pullback makes some sense. * 7 Healthy Dividend Stocks to Buy for Extra Stability HLF has put many of its risks behind it. It continues to grow earnings. But 2019 guidance isn't quite as good as investors were hoping for -- and with the stock not far off its highs, more was priced in.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Herbalife EarningsQ4 earnings from Herbalife appear relatively in line with overall expectations. Adjusted earnings per share of 63 cents did decline 3% year over year, but the figure came in 2 cents above analyst expectations. Revenue growth of 9% matched the Street consensus, though an early January update from Herbalife had pointed analysts in the right direction.So, there wasn't much in the way of surprise -- and likely little to change the minds of either bulls or bears. HLF bulls can point to strong performance in both Q4 and for the full year, over which time sales rose 10%. A 30% rise in "volume points" in Asia Pacific during the fourth quarter shows continued improvement in that key Herbalife market.With regulatory pressure in the U.S. seemingly behind the company, that growth is what matters to Herbalife stock. And the company is delivering.The one piece of somewhat disappointing news came in terms of 2019 guidance. Herbalife projects EPS of $2.90-$3.10 for 2019. That's below analyst consensus of $3.20. Currency headwinds may be a factor, however: HLF is guiding for a 22-cent impact on this year's earnings from the stronger dollar. Including that impact, the midpoint of adjusted EPS guidance suggests less than 1% growth. Backing out those external effects, however, Herbalife earnings (on a non-GAAP basis) should rise more than 8% year over year. The HLF Stock Battleground Remains IntactAgain, Q4 results and 2019 guidance likely do little to change the mind of investors on either side of the HLF trade. Bulls see continued growth on both the top and bottom line. The smaller, but still-vocal, bearish contingent will point out, as Josh Enomoto did, that the company still is a multi-level marketer (MLM).Yes, Herbalife settled with U.S. regulators. But foreign entities may have different standards -- a potential risk as Herbalife increasingly focuses as international growth. The stronger dollar makes the potential profit for that risk even smaller, at least for U.S. shareholders.Even the sudden departure of the company's then-CEO last month can be viewed in different ways. It turned out that Richard Goudis was caught on tape telling an employee in Asia to ignore expense-account limits on entertainment. To bears, this was a sign that the company's culture, even at the top, was based on skirting the rules.Yet, Herbalife stock actually touched its all-time high a few weeks after Goudis' departure, likely in part because traders thought the exit opened up the possibility of a go-private deal. Here, too, both sides viewed the news through their own respective lens. Herbalife Stock Isn't CheapFrom here, the HLF battleground looks likely to result in a stalemate after the Q4 report. Bears aren't going anywhere. Neither are bulls. And the valuation assigned to Herbalife stock looks about right -- if not a touch high.The midpoint of 2019 EPS guidance suggests an 18.8 P/E multiple for HLF. That's a multiple that assumes some growth -- and about what Herbalife is projecting it will post in 2019. From that standpoint, HLF looks reasonably valued.But there are risks underlying the story here -- even if bears have overestimated those risks in the past. Note that other MLMs like Nu Skin Enterprises (NYSE:NUS) and Medifast (NYSE:MED) have taken big hits in recent months. (Medifast admittedly had soared before pulling back by roughly 50%; that stock still is up 89% over the past year.)In that context, unless HLF's growth expectations rise over the course of the year, it's tough to see Herbalife stock clearing $60 again. 20 times $3 per share in earnings looks like a potential ceiling -- and suggests just 6.7% returns from this level. * 7 Restaurant Stocks to Watch in 2019 And it's worth remembering that for the first half of the decade, HLF was a volatile stock -- but one that traded mostly sideways. Right now, I'd expect that type of trading to return in 2019 (although, perhaps, in a tighter range given the lower short interest). Q4 results were good, and Herbalife is going to grow. But that's already priced in. For the next few quarters at least, the movement in HLF is going to come down to whether the company can beat guidance -- and whether the bulls can hold off the bears.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 10 Best Cheap Stocks to Buy Right Now * 5 Stocks Under $5 to Buy Before They Soar * 5 Consumer Stocks to Cash Out Of Compare Brokers The post Earnings Signify the End of the Rally in Herbalife Stock appeared first on InvestorPlace.
Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! After reading Nu Skin Enterprises, Inc.'s (NYSE:NUS) most recent earningsRead More...